NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Ovid Therapeutics (OVID) Technical (Analysis) Reports Ovid Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Ovid Therapeutics (OVID)

Technical Analysis Report for USA stock OVID Ovid Therapeutics. Dated: 14 May 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock OVID Ovid Therapeutics then click here. or read Experts views on Ovid Therapeutics or Forecast & share price targets of Ovid Therapeutics

Ovid Therapeutics Opened at 2.80 and Closed at: 2.81, which is 0.36% of previous session's close. It moved within a range of 2.75 and 2.90
The session was a Bullish session with an average volume of 1162142, which is -57.55% of previous session's volumes.

• The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
• The stock has shown an up move, and its long term trend is also positive and in an uptrend.

A Golden cross was found 4 days back on short term averages

Support for tomorrow is 2.78 and resistance for tomorrow is 2.93
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 2.74, 2.67 resistance for tomorrow's hourly charts is 2.89, 2.97

10 Day SMA for Ovid Therapeutics (OVID) is 2.81 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Ovid Therapeutics (OVID) is 2.77 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Ovid Therapeutics (OVID) is 2.52 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 2.07 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Ovid Therapeutics is 1.69 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Ovid Therapeutics is at 2.77 and 200 DMA is at 1.69, while 50 DMA and 100 DMA are at 2.52 and 2.07 respectively

Ovid Therapeutics (OVID) moving average of 20 SMA is at 2.77 and 20 EMA is at 2.76

Ovid Therapeutics (OVID) moving average of 50 SMA is at 2.52 and 50 EMA is at 2.51

Ovid Therapeutics (OVID) moving average of 100 SMA is at 2.07 and 100 EMA is at 2.16

Ovid Therapeutics (OVID) moving average of 200 SMA is at 1.69 and 200 EMA is at 1.72

Tenet Healthcare has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in Tenet Healthcare, about 6.58% more returns!

Cigna Corporation has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in Cigna Corporation, about 8.16% more returns!

Ovid Therapeutics has performed better than Biohaven Pharmaceutical in short term. Holding Ovid Therapeutics could be a better choice for now!

Ovid Therapeutics has performed better than Therapeuticsmd Inc in short term. Holding Ovid Therapeutics could be a better choice for now!

Tonix Pharmaceuticals has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in Tonix Pharmaceuticals, about 0.96% more returns!

Ovid Therapeutics has performed better than Tenax Therapeutics in short term. Holding Ovid Therapeutics could be a better choice for now!

Supernus Pharmaceuticals has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in Supernus Pharmaceuticals, about 2.67% more returns!

Ovid Therapeutics has performed better than Sarepta Therapeutics in short term. Holding Ovid Therapeutics could be a better choice for now!

Ultragenyx Pharmaceutical has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in Ultragenyx Pharmaceutical, about 5.72% more returns!

National Research has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in National Research, about 6.9% more returns!

Ovid Therapeutics has performed better than Moleculin Biotech in short term. Holding Ovid Therapeutics could be a better choice for now!

Liquidia Technologies has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in Liquidia Technologies, about 60.18% more returns!

Ovid Therapeutics has performed better than Innoviva Inc in short term. Holding Ovid Therapeutics could be a better choice for now!

Fonar Corporation has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in Fonar Corporation, about 3.09% more returns!

Dariohealth Corp has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in Dariohealth Corp, about 15.24% more returns!

Ovid Therapeutics has performed better than Cytomx Therapeutics in short term. Holding Ovid Therapeutics could be a better choice for now!

Corbus Pharmaceuticals has performed better than Ovid Therapeutics in short term. You could have earned much better returns by investing in Corbus Pharmaceuticals, about 15.79% more returns!

Ovid Therapeutics has performed better than Align Technology in short term. Holding Ovid Therapeutics could be a better choice for now!

Ovid Therapeutics Technical analysis of indicators

Price action analysis of Ovid Therapeutics (OVID) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Ovid Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Ovid Therapeutics in short term but the sell signal is initial and weak.

Ovid Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up

CCI has generated a buy signal for Ovid Therapeutics in short term but BUY signal is weak.

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in positive zone. This is a BUY zone

Although the stock is in the BUY zone, but buying might be slowing down

Stock of Ovid Therapeutics is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2.82 and Ovid Therapeutics OVID stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Ovid Therapeutics OVID stock. Volume based technical analysis of Ovid Therapeutics OVID stock is negative.

Ovid Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock OVID Ovid Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And OVID Experts View which covers a lot of information including buying and selling signals

OVID future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Ovid Therapeutics or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet